🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I study designed to assess the maximum tolerated dose (MTD)...
Status
Withdrawn
Location
Montefiore Medical Center
Start Date
2019-09-11
Trial ID
NCT03057990
Treatments Being Tested
The objective of this study will be to evaluate the safety, tolerability an...
Status
Completed
Location
Weill Cornell Medical Center/New York Presbyterian Hospital
Start Date
2009-11
Trial ID
NCT01083667
Treatments Being Tested
This study aims to investigate the pharmacokinetic/pharmacodynamic drug-dru...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2013-06
Trial ID
NCT01973933
Treatments Being Tested
We investigate whether the add-on specific antitoxoplasmatic medication has...
Status
Completed
Location
Multiple Locations
Start Date
2002-01
Trial ID
NCT00300404
Treatments Being Tested
This study will examine whether the drug pyrimethamine can shrink lymph nod...
Status
Completed
Location
National Institute of Allergy and Infectious Diseases (NIAID)
Start Date
2003-07
Trial ID
NCT00065390
Treatments Being Tested
NRF2 activation, observed in up to 40% of head and neck squamous cell carci...
Status
Completed
Location
Washington University School of Medicine
Start Date
2023-08-03
Trial ID
NCT05678348
Treatments Being Tested
A translational proof of concept study in humans on the primary research qu...
Status
Completed
Location
Erasmus MC
Start Date
2018-04-18
Trial ID
NCT03525730
Treatments Being Tested
In this research study we will start by looking for the highest dose of pyr...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2010-03
Trial ID
NCT01066663
Treatments Being Tested
Background : When a mother contracts toxoplasmosis during pregnancy, the pa...
Status
Completed
Location
Hôpital Louis Mourier
Start Date
2010-11
Trial ID
NCT01189448
Treatments Being Tested